2024-515254-24-00
Active, not recruiting
Phase 1
A study to investigate the safety, the amount that reaches the bloodstream and the effects on the body of JNJ-64619178 in people with advanced cancers
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Janssen Cilag International
- Enrollment
- 74
- Locations
- 1
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
CTIS Point of Contact
Scientific
Janssen Cilag International
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Phase 1
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).2024-515074-26-00AgomAb Therapeutics64
Completed
Not Applicable
Safety and tolerability of a vaginal ointment without any active drugs in healthy women.ACTRN12617000778381Zenith Technology Corporation Limited9
Not yet recruiting
Not Applicable
Study to determine the safety and tolerability of combination therapy of TACE (Transarterial-chemoembolization) and Immunotherapy With the Autologous Killer Cell in patients with hepatocellular carcinoma: An open label studyKCT0007346Bundang CHA General Hospital10
Recruiting
Not Applicable
A study on the safety and effectiveness of "a weight loss program by setting energy intake considering changes in basal metabolic rate"ObesityJPRN-UMIN000044385Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine20
Completed
Phase 1
A study to investigate the safety, tolerability, and pharmacokinetics of Ent001 in patients with moderately to severely active ulcerative colitis2023-507340-36-00Enthera S.r.l.40